Introduction
Recurrent pregnancy loss is usually identified after a person has experienced repeated miscarriages, most often defined in clinical practice as two or more pregnancy losses. The diagnosis is not based on a single symptom, but on a pattern of documented pregnancy failures and the search for an underlying cause. Because early pregnancy loss is common, doctors do not assume that repeated miscarriage is random; instead, they evaluate whether an identifiable genetic, anatomical, hormonal, autoimmune, or clotting-related problem may be interfering with the ability to maintain a pregnancy.
Accurate diagnosis matters because recurrent pregnancy loss can reflect very different biological mechanisms. In some patients the problem is with the embryo, such as a chromosomal abnormality. In others, the uterine cavity may not support implantation or placental development, or the maternal immune and clotting systems may be affecting placental blood flow. A structured evaluation helps distinguish these possibilities and guides treatment decisions.
Recognizing Possible Signs of the Condition
The most important clinical sign is a history of repeated pregnancy loss. These losses often occur in the first trimester, but recurrent pregnancy loss can also involve second-trimester miscarriages or fetal losses later in gestation. The pattern of loss can suggest different causes. Very early losses may point toward chromosomal errors in the embryo, while losses after a heartbeat has been seen can raise concern for uterine abnormalities, antiphospholipid syndrome, or inherited and acquired maternal disorders.
Patients may also report bleeding, cramping, or passage of tissue during each miscarriage, but these findings are not specific to recurrent pregnancy loss. The suspicion usually arises from the recurrence itself, especially when previous pregnancies were confirmed by ultrasound or pregnancy testing. Clinicians also pay attention to whether losses were consecutive, how far each pregnancy progressed, and whether there is a history of infertility, stillbirth, preterm birth, or complications such as preeclampsia. These details help determine whether the issue is limited to early implantation failure or reflects a broader disorder of pregnancy maintenance.
Medical History and Physical Examination
Evaluation begins with a detailed medical and reproductive history. Doctors usually ask about the number of pregnancies, timing of each loss, whether the losses were clinically confirmed, and whether any fetal tissue was tested. A history of miscarriage before six weeks may suggest one pattern, while later loss may suggest another. They also ask about prior live births, infertility treatment, menstrual regularity, pelvic pain, known uterine disease, sexually transmitted infections, and any previous surgery involving the uterus or cervix.
Family history is important because some causes are inherited or cluster in families. A clinician may ask about blood clots, autoimmune disease, congenital uterine anomalies, or repeated pregnancy loss in relatives. Medical history also includes thyroid disease, diabetes, polycystic ovary syndrome, obesity, chronic kidney disease, and use of medications, tobacco, alcohol, or drugs that can affect pregnancy. Prior thrombotic events, migraines with aura, rashes, joint symptoms, or other autoimmune features may increase suspicion for antiphospholipid syndrome or another systemic disorder.
The physical examination is often normal, but it can identify clues that direct testing. A pelvic examination may reveal uterine enlargement, tenderness, cervical abnormalities, or signs of infection. General examination may look for thyroid enlargement, signs of androgen excess, obesity, features of connective tissue disease, or evidence of endocrine disease. If there is concern for a structural uterine problem, prior pelvic surgery, or congenital reproductive tract anomaly, the exam may prompt targeted imaging rather than provide a diagnosis itself.
Diagnostic Tests Used for Recurrent pregnancy loss
The workup is typically organized around the major biologic categories known to contribute to miscarriage. Because multiple causes can coexist, clinicians often order several tests rather than relying on one study.
Laboratory tests commonly include thyroid function tests, hemoglobin A1c or glucose testing, and sometimes prolactin when ovulatory dysfunction is suspected. These tests help identify endocrine disturbances that can impair implantation, placentation, or early fetal development. Thyroid disease is a frequent example because both underactive and overactive thyroid function can affect pregnancy maintenance. Diabetes screening is important because poor glycemic control can increase miscarriage risk through effects on embryonic development and placental function.
Testing for antiphospholipid syndrome is one of the most important laboratory evaluations. This usually involves lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. These markers indicate an autoimmune tendency to form clots and interfere with placental circulation. In recurrent pregnancy loss, the significance is not just the presence of antibodies but whether they meet accepted criteria on repeated testing over time and whether they are associated with pregnancy complications or thrombosis.
Some patients undergo genetic testing, especially if there is a history of repeated early loss or abnormal fetal tissue results. A parental karyotype can detect balanced chromosomal rearrangements such as translocations, which may not affect the parent but can produce embryos with unbalanced genetic material. This type of problem can lead to repeated miscarriage because the embryo may not develop normally.
Imaging tests are used to assess the uterus and its cavity. Transvaginal ultrasound is often the first imaging study because it can detect fibroids, polyps, adenomyosis, congenital uterine anomalies, and retained tissue. Saline infusion sonography, also called sonohysterography, can give a clearer view of the uterine cavity by expanding it with saline. Hysterosalpingography uses contrast and X-ray imaging to outline the uterine cavity and fallopian tubes, which can reveal septate uterus, adhesions, or other structural abnormalities. In selected cases, MRI is used when ultrasound findings are unclear or when a complex uterine anomaly is suspected.
Functional tests may be used to understand whether the reproductive system is functioning normally rather than only whether anatomy looks normal. Examples include ovulatory assessment when irregular cycles suggest anovulation, and, in some centers, evaluation of luteal phase or hormonal patterns when endocrine causes are suspected. These tests are less central than imaging and laboratory studies, but they may help if the history suggests inconsistent ovulation or hormonal instability. In addition, cervical assessment may be considered if losses occur in the second trimester and cervical insufficiency is a possibility.
Tissue examination of pregnancy loss products can be highly informative when tissue is available. Chromosomal analysis of fetal tissue, now often performed with chromosomal microarray or other genetic methods, can show whether the miscarriage resulted from a sporadic aneuploidy such as trisomy. This information helps distinguish a random fetal genetic event from a recurrent maternal or paternal condition. Placental or fetal pathology may also identify infection, inflammation, or structural abnormalities. If tissue confirms a genetically normal pregnancy loss, doctors become more suspicious of maternal, uterine, immune, or clotting causes.
Interpreting Diagnostic Results
Doctors interpret results by matching them to the timing and pattern of losses. If fetal tissue shows a chromosomal abnormality, the miscarriage may be classified as likely sporadic rather than due to a persistent maternal disorder. However, if abnormal results recur or if a parent carries a balanced translocation, a hereditary mechanism becomes more likely. A normal fetal genetic study does not prove a maternal cause, but it shifts attention toward the uterine environment, clotting disorders, endocrine disease, or immune factors.
Abnormal thyroid studies, poor glucose control, or elevated prolactin can support an endocrine diagnosis when they are consistent with the clinical picture. Positive antiphospholipid antibody testing must be interpreted carefully, because transient positivity can occur. A diagnosis of antiphospholipid syndrome depends on meeting laboratory criteria and clinical pregnancy or clotting criteria, not just one abnormal test. Similarly, a uterine abnormality found on imaging does not automatically explain every loss unless the anatomy is significant enough to affect implantation or fetal growth.
Clinicians also interpret the number and timing of losses. Repeated very early losses with no live birth may suggest a strong embryonic genetic component, particularly in older patients. Losses after confirmation of a fetal heartbeat or second-trimester losses may increase the likelihood of structural uterine problems, cervical insufficiency, or antiphospholipid syndrome. The overall diagnosis is therefore a synthesis of history, laboratory data, imaging, and pathology rather than a single definitive test.
Conditions That May Need to Be Distinguished
Several other conditions can mimic recurrent pregnancy loss or coexist with it. Isolated miscarriage is the most common alternative diagnosis, especially when only one pregnancy has been lost. Because early pregnancy loss is common, clinicians distinguish a true recurrent pattern from unrelated single events.
Biochemical pregnancies, where a positive pregnancy test is followed by very early loss before ultrasound confirmation, may be confused with recurrent miscarriage. Doctors may rely on documentation of pregnancy tests or ultrasound findings to decide whether the losses meet criteria for evaluation. Ectopic pregnancy can also present with bleeding and pain, but it is located outside the uterus and is diagnosed by ultrasound and hormone trends rather than as recurrent miscarriage.
Structural problems such as uterine septum, submucosal fibroids, intrauterine adhesions, or cervical insufficiency can produce repeated losses but may be treatable once identified. Hormonal disorders including uncontrolled diabetes, thyroid disease, and ovulatory dysfunction may cause pregnancy failure through altered implantation or placental development. Autoimmune disease, particularly antiphospholipid syndrome, must be separated from inherited thrombophilias because the evidence and treatment approach differ. In many patients, more than one factor may contribute, so physicians look for the combination rather than a single explanation.
Factors That Influence Diagnosis
Several factors affect how extensive the diagnostic evaluation should be. Maternal age is important because the risk of embryonic chromosomal abnormalities rises with age, especially after 35. In an older patient, repeated losses may be more likely to involve aneuploid embryos, which influences how genetic testing is interpreted. In younger patients, repeated miscarriage may prompt a stronger search for anatomical or autoimmune causes.
The number of losses also influences the threshold for testing. Some clinicians begin a full evaluation after two losses, while others may reserve broader workup for three or more, depending on the patient’s age and history. The gestational age of the losses matters as well. Very early losses often require different interpretation than second-trimester events. A prior live birth does not exclude recurrent pregnancy loss, but it may suggest that a new acquired problem, such as antiphospholipid syndrome or uterine scarring, developed after a previous successful pregnancy.
Other health conditions can complicate diagnosis. Obesity, insulin resistance, autoimmune disease, and prior uterine surgery may all alter the probability of certain causes. Use of assisted reproductive technologies can also change the interpretation of genetic findings and pregnancy timing. In some cases, a complete cause is not found even after thorough testing; this is common and does not mean the evaluation was unhelpful, because it still rules out major treatable disorders.
Conclusion
Recurrent pregnancy loss is diagnosed through a structured medical evaluation that combines pregnancy history, physical examination, laboratory testing, imaging, and sometimes tissue analysis. The goal is not simply to confirm that miscarriages occurred, but to identify the biologic reason they are happening. That reasoning may point to embryonic chromosomal abnormalities, uterine structural problems, endocrine disease, antiphospholipid syndrome, or less common maternal factors.
By interpreting the timing, frequency, and pattern of pregnancy loss alongside targeted test results, clinicians can distinguish recurrent pregnancy loss from isolated miscarriage and from other pregnancy complications. This careful diagnostic process is essential because it determines whether a patient needs genetic counseling, uterine repair, endocrine treatment, anticoagulation, or further specialist evaluation. In many cases, the diagnosis is reached only after assembling several pieces of evidence into one clinical picture.